Venkat Nageswar Chalasani resigns as Independent Director of Aurobindo Pharma arm Apitoria Pharma

Published On 2023-11-17 08:00 GMT   |   Update On 2023-11-18 11:29 GMT
Advertisement

HyderabadThrough a recent BSE filing, Aurobindo Pharma has recently informed that Venkat Nageswar Chalasani has resigned as the Independent Director of Apitoria Pharma Private Limited, a wholly-owned subsidiary of the Company, with effect from November 13, 2023, due to his other preoccupation, i.e. he has been appointed as Chief Executive of the Association of Mutual Funds in India and to avoid conflict of interest.

Advertisement

Mr. Venkat Nageswar retired as Deputy Managing Director, International Banking Group of State Bank of India on April 30, 2021. With over 37 years of experience spanning across various distinguished positions in the Bank pan India and abroad, he worked in all the areas of Banking - Credit, Treasury, Retail, International Banking, Finance, Risk Management etc. He has also held CFO position of the Bank for a brief period. He has been part of committees set up by the Reserve Bank of India (RBI) and the Ministry of Finance. He has also been the Chairman of the Fixed Income Money Market and Derivatives Association of India (FIMMDA) and the Foreign Exchange Dealers Association of India (FEDAI).

Read also: Aurobindo Pharma arm Apitoria Pharma appoints new CEO, Independent Director

Aurobindo Pharma Limited is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and commercializes a wide range of generic pharmaceuticals, branded specialty pharmaceuticals and active pharmaceutical ingredients globally in over 150 countries. The company has 24 manufacturing and packaging facilities that are approved by leading regulatory agencies including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, Brazil ANVISA. The company’s product portfolio is spread over 7 major therapeutic/product areas encompassing CNS, AntiRetroviral, CVS, Antibiotics, Gastroenterological, Anti-Diabetics and Anti-Allergic.

Read also: Aurobindo Pharma appoints Dr Satakarni Makkapati as Non executive, Non independent Director

Tags:    
Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News